Literature DB >> 25748311

Cutaneous manifestations of pediatric granulomatosis with polyangiitis: a clinicopathologic and immunopathologic analysis.

Adam C Wright1, Lawrence E Gibson2, Dawn Marie R Davis1.   

Abstract

BACKGROUND: Granulomatosis with polyangiitis (GPA) is a rare systemic vasculitis associated with variable cutaneous manifestations and histopathologic findings. It is less frequent in children than adults and is often positive for cytoplasmic antineutrophil cytoplasmic antibody (ANCA) or proteinase 3-ANCA.
OBJECTIVE: We sought to better define and correlate the clinical, histopathologic, and immunopathologic characteristics of cutaneous GPA in pediatric patients.
METHODS: We retrospectively reviewed clinical records and cutaneous histopathologic specimens of patients 17 years or younger with cutaneous manifestations of GPA who were seen at our institution from 1990 to 2013.
RESULTS: Of the 52 patients identified with GPA, cutaneous involvement occurred in 36.5% and was the initial manifestation of disease in 7.7%. Of the 19 patients with cutaneous involvement, 26.3% developed acneiform and folliculitis-like papules; 84.2% were cytoplasmic ANCA positive; and 78.9% were proteinase 3-ANCA positive. Histopathologic features included leukocytoclastic vasculitis, granulomatous inflammation, acneiform and perifollicular inflammation, granulomatous vasculitis, and palisading granulomas. LIMITATIONS: Our study was limited because of its retrospective design.
CONCLUSION: Pediatric patients with cutaneous GPA most commonly have palpable purpura, leukocytoclastic vasculitis, and positive cytoplasmic ANCA or proteinase 3-ANCA serologic results. Cutaneous manifestations and histopathologic findings vary, but acneiform lesions may be a cutaneous manifestation of the disease unique to this age group.
Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Wegener granulomatosis; acneiform lesions; antineutrophil cytoplasmic antibodies; cytoplasmic antineutrophil cytoplasmic antibody; granuloma; granulomatosis with polyangiitis; granulomatous inflammation; palpable purpura; proteinase 3 antineutrophil cytoplasmic antibody; vasculitis

Mesh:

Substances:

Year:  2015        PMID: 25748311     DOI: 10.1016/j.jaad.2015.01.043

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

Review 1.  Pyoderma gangrenosum-like ulcerations in granulomatosis with polyangiitis: two cases and literature review.

Authors:  Giovanni Genovese; Simona Tavecchio; Emilio Berti; Franco Rongioletti; Angelo Valerio Marzano
Journal:  Rheumatol Int       Date:  2018-05-02       Impact factor: 2.631

2.  Unilateral eyelid edema and mucosal involvement as the first presentations of Wegener granulomatosis.

Authors:  Rana Rafiei; Narges Alizadeh; Kaveh Gharaei Nejad; Behnam Rafiee; Sara Najirad
Journal:  Caspian J Intern Med       Date:  2019

3.  Three Patterns of Cutaneous Involvement in Granulomatosis with Polyangiitis.

Authors:  Gaafar Ragab; Mohamed Tharwat Hegazy; Mohamed Ali; Mona R E Abdel-Halim; Xavier Puéchal
Journal:  J Adv Res       Date:  2020-05-07       Impact factor: 10.479

4.  Pyoderma gangrenosum-like ulceration as a presenting feature of pediatric granulomatosis with polyangiitis.

Authors:  Rotem Semo Oz; Oluwakemi Onajin; Liora Harel; Rotem Tal; Tomas Dallos; Adena Rosenblatt; Lukas Plank; Linda Wagner-Weiner
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-05       Impact factor: 3.054

5.  Cutaneous Manifestations of Granulomatosis with Polyangiitis: A Case Series Study.

Authors:  Trinidad Montero-Vilchez; Antonio Martinez-Lopez; Luis Salvador-Rodriguez; Maria Del Carmen Ramírez-Barberena; Jesus Tercedor-Sanchez; Alejandro Molina-Leyva; Salvador Arias-Santiago
Journal:  Acta Derm Venereol       Date:  2020-05-28       Impact factor: 3.875

6.  Azathioprine therapy for steroid-resistant Henoch-Schönlein purpura: a report of 6 cases.

Authors:  Lampros Fotis; Paul V Tuttle; Kevin W Baszis; Peri H Pepmueller; Terry L Moore; Andrew J White
Journal:  Pediatr Rheumatol Online J       Date:  2016-06-23       Impact factor: 3.054

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.